Diagnosing irritable bowel syndrome is one of the most nuanced processes in modern gastroenterology, precisely because IBS is a condition defined by symptoms rather than visible structural damage. If you have been experiencing persistent abdominal pain, bloating, or unpredictable bowel habits, understanding how healthcare professionals approach IBS — and why a diagnosis alone may not reveal the full picture of what is happening in your gut — can empower you to take more informed next steps. This article explains what IBS is, how it is diagnosed, why symptoms vary so dramatically between individuals, and how gut microbiome testing may provide an additional layer of personalized insight alongside conventional medical evaluation.

What is Irritable Bowel Syndrome (IBS)?

Irritable bowel syndrome is classified as a functional gastrointestinal disorder, meaning that the digestive system does not work as it should despite appearing structurally normal on standard imaging or endoscopic examination. This distinguishes IBS from inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, as well as from other conditions where visible tissue damage, obstruction, or growths can be identified.

The term "functional" reflects the current understanding that IBS arises from disrupted physiological processes rather than from a disease that can be seen with a camera or a scan. The Rome IV criteria, the internationally recognized standard for diagnosing IBS, define it as recurrent abdominal pain occurring at least one day per week on average over the previous three months, associated with two or more of the following: a relationship between pain and defecation, a change in stool frequency, or a change in stool form. IBS is increasingly understood as a disorder of gut-brain interaction, meaning that communication between the central nervous system and the enteric nervous system of the gut plays a central role in symptom generation.

IBS is estimated to affect a significant proportion of the global population, with prevalence figures typically cited in the range of 4–11% depending on the diagnostic criteria and region studied. Its impact on quality of life, work productivity, and emotional wellbeing is well documented, making it one of the most commonly encountered conditions in both primary care and gastroenterology clinics.

What are the Main Symptoms of IBS?

The core symptoms of IBS include:

• Abdominal pain or discomfort, often described as cramping, which is typically at least partially relieved by defecation.
• Bloating, which may range from a mild sensation of fullness to visible abdominal distension.
• Changes in bowel habits, including diarrhea, constipation, or an alternating pattern between the two.

Based on the predominant bowel pattern, IBS is classified into subtypes:

1. IBS-D (diarrhea-predominant): characterized by loose or watery stools occurring more frequently.
2. IBS-C (constipation-predominant): characterized by hard or lumpy stools and infrequent bowel movements.
3. IBS-M (mixed): characterized by both constipation and diarrhea occurring in the same individual.

Some individuals with IBS also report passing mucus with stools or experiencing a persistent sensation of incomplete evacuation after a bowel movement. These additional features, while not part of the formal diagnostic criteria, are frequently described and can contribute to the overall burden of the condition.

The Diagnostic Process: How is IBS Diagnosed?

Diagnosing irritable bowel syndrome is fundamentally a clinical process. There is no single blood test, scan, or biomarker that definitively confirms IBS. Instead, healthcare professionals use a structured approach that combines validated symptom criteria, a careful medical history, a physical examination, and — where indicated — targeted testing to exclude other conditions that may mimic IBS.

This means that IBS is often described as a diagnosis of exclusion, although in contemporary practice, a more accurate framing is that IBS is diagnosed positively based on characteristic symptom patterns combined with the absence of warning signs that would point toward an alternative diagnosis. A clinical diagnosis made using the Rome IV criteria differs from a full diagnostic workup, which involves objective testing.

The Role of Medical History and Physical Exam

During the diagnostic process, a doctor will typically ask detailed questions about:

• The duration, frequency, and character of symptoms.
• Any relationship between symptoms and food, stress, or the menstrual cycle.
• Family history of gastrointestinal conditions, including colorectal cancer, celiac disease, and IBD.
• Sleep quality, energy levels, and psychological wellbeing.
• Current medications and prior gastrointestinal surgeries.

A physical examination helps to assess for abdominal tenderness, distension, masses, or other findings that might suggest a structural abnormality. The doctor will also screen for "red flag" symptoms, which are features that raise concern for a condition other than IBS and prompt further investigation. These include:

• Unintentional weight loss.
• Rectal bleeding or blood in the stool.
• Anemia identified on blood testing.
• Onset of symptoms after the age of 50 without prior colorectal screening.
• Fever or night-time symptoms that wake the individual from sleep.
• A family history of colorectal cancer, IBD, or celiac disease.

The presence of any red flag symptom does not mean that IBS is not also present, but it does mean that additional conditions must be ruled out before a confident diagnosis can be made.

Tests Used to Rule Out Other Conditions

Depending on the clinical picture, a doctor may order tests to exclude conditions that share symptoms with IBS. Common differential diagnoses include:

• Celiac disease: an immune reaction to gluten that can cause bloating, diarrhea, and abdominal discomfort. Blood tests for tissue transglutaminase antibodies are commonly used.
• Inflammatory bowel disease (IBD): Crohn's disease and ulcerative colitis can cause diarrhea, abdominal pain, and fatigue. Tests such as fecal calprotectin (a marker of intestinal inflammation), C-reactive protein (CRP), and colonoscopy are typically employed.
• Colorectal cancer: particularly relevant in older individuals or those with red flag symptoms. Colonoscopy is the primary investigation.
• Bile acid malabsorption: a condition that can cause chronic diarrhea and may be tested using a SeHCAT scan in some regions.
• Parasitic or bacterial infections: stool testing can identify persistent infections that may masquerade as IBS symptoms.

When these tests return normal results and the symptom pattern is consistent with the Rome IV criteria, a diagnosis of IBS can be made with reasonable confidence.

Why Do I Have IBS? Looking at the Causes and Triggers

One of the most common questions following a diagnosis is: why did this happen? The honest answer is that IBS does not have a single identifiable cause. Instead, research indicates that it arises from a combination of overlapping factors that differ between individuals. The main mechanisms currently understood to contribute include:

• Altered gut motility: the muscular contractions of the digestive tract may become too fast, too slow, or poorly coordinated, leading to diarrhea, constipation, or cramping.
• Visceral hypersensitivity: the nerves in the gut wall become more reactive to normal stimuli such as gas, stretching, or stool movement.
• Disrupted gut-brain signaling: communication between the brain and the gut may become dysregulated, amplifying pain perception and altering digestive function.
• Gut microbiome imbalance: changes in the composition and function of the gut microbial community may contribute to symptom generation.
• Post-infectious changes: some individuals develop IBS-like symptoms following an episode of gastroenteritis, a phenomenon known as post-infectious IBS.
• Genetic and environmental factors: family history, early life stress, and dietary patterns all appear to influence risk.

The Gut-Brain Axis and Visceral Hypersensitivity

The gut-brain axis refers to the bidirectional communication network connecting the central nervous system with the enteric nervous system of the digestive tract. This axis involves neural pathways (primarily the vagus nerve), hormonal signals, and immune mediators. When gut-brain signaling becomes dysregulated, normal digestive sensations — such as the movement of gas or the stretching of the intestinal wall — may be perceived as painful or uncomfortable. This heightened sensitivity is known as visceral hypersensitivity.

Importantly, psychological stress is not merely a "side effect" of living with IBS but can act as a genuine biological driver of symptoms. Stress hormones such as cortisol can directly alter gut motility, increase intestinal permeability, and modify pain processing pathways. This does not mean that IBS is "all in the head" — it means that the brain and the gut are deeply interconnected in ways that produce real, physical symptoms.

The Role of the Gut Microbiome in IBS Symptoms

The gut microbiome refers to the vast community of microorganisms — including bacteria, fungi, archaea, and viruses — that inhabit the digestive tract, with the highest concentrations found in the colon. This community contains trillions of individual microbes and collectively performs functions that influence digestion, immune regulation, nervous system signaling, and the production of bioactive compounds.

Research over the past two decades has consistently found that many individuals with IBS have a gut microbial composition that differs from those without the condition. This state of altered microbial balance is often referred to as dysbiosis. Specific observations in IBS populations have included reduced overall bacterial diversity, shifts in the relative abundance of certain bacterial groups, and changes in metabolic function.

Several mechanisms have been proposed to explain how dysbiosis might contribute to IBS symptoms:

• Increased intestinal permeability: some research suggests that certain microbial profiles may be associated with a "leakier" gut barrier, allowing bacterial products to interact with the immune system and potentially trigger low-grade local inflammation.
• Altered fermentation: different bacterial communities produce different amounts and types of gas (hydrogen, methane, hydrogen sulfide) and short-chain fatty acids, which can influence motility, sensation, and bloating.
• Immune activation: dysbiosis may stimulate the gut-associated immune system in ways that contribute to visceral hypersensitivity.
• Neuroactive metabolites: certain gut bacteria produce compounds that can influence nerve function and pain signaling.

It is important to note that while these associations are well documented in the research literature, a clear cause-and-effect relationship between specific microbial changes and IBS symptoms has not been definitively established in all cases. The relationship appears to be bidirectional — IBS may alter the microbiome, and the microbiome may contribute to IBS symptoms.

Why Symptoms Alone Don't Tell the Whole Story (Individual Variability)

One of the most striking features of IBS is how differently it manifests from person to person. Two individuals with the same diagnosis may have completely different trigger foods, symptom patterns, severity levels, and responses to treatment. This variability reflects the underlying complexity of the condition — which involves an individual's unique genetics, life stress history, dietary habits, immune profile, and gut microbial signature.

This is also why symptoms alone cannot reliably reveal the underlying cause. Bloating, for example, could reflect excessive gas production by specific bacterial groups, altered motility, visceral hypersensitivity, or a combination of all three. Abdominal pain could stem from visceral hypersensitivity, local inflammation, or dysregulated gut-brain signaling. Without additional information about what is actually happening within the gut ecosystem, it can be difficult to identify which mechanism is most relevant for any given individual.

The "One-Size-Fits-All" Problem in IBS Management

Standard treatment approaches for IBS — such as antispasmodic medications, peppermint oil, or general dietary advice — can provide meaningful relief for some individuals but may be ineffective for others. This is not surprising given the heterogeneity of the condition. A person whose symptoms are primarily driven by visceral hypersensitivity may respond well to neuromodulator therapy, while someone whose symptoms are linked to specific bacterial fermentation patterns may benefit more from targeted dietary modification.

A similar challenge exists with dietary interventions. The low-FODMAP diet, while effective for many, is highly restrictive and is not designed to be followed indefinitely. When individuals attempt to eliminate foods based on guesswork or generic online advice, they may unnecessarily restrict entire food groups, risk nutritional deficiencies, or follow an unsustainable dietary pattern that does not address their actual underlying issue. Without information about which microbes are present and what they are capable of doing, dietary "trial and error" can become frustrating, prolonged, and nutritionally suboptimal.

The Connection Between IBS and Gut Microbiome Imbalance

Understanding the relationship between IBS and the gut microbiome requires moving beyond the general diagnosis to examine the specific features of an individual's gut ecology. While a clinical diagnosis tells you that you have IBS, it does not tell you why your gut is producing the symptoms you experience — nor does it reveal the specific microbial composition that may be contributing to your unique symptom profile.

Small Intestinal Bacterial Overgrowth (SIBO) and IBS

Small intestinal bacterial overgrowth (SIBO) refers to a condition in which bacteria that normally reside primarily in the colon migrate or proliferate in the small intestine. The small intestine is designed to have relatively low bacterial counts, and when bacteria establish themselves there, they can ferment food substrates before they have been fully absorbed, producing gas (hydrogen, methane, or hydrogen sulfide) in a location where it normally would not be produced in such quantities.

The resulting gas production can cause distension, bloating, cramping, and altered bowel habits — symptoms that closely overlap with those of IBS. Research has explored the relationship between SIBO and IBS for many years, and while the prevalence of SIBO among individuals with IBS-like symptoms varies considerably across studies (depending on the testing method and population studied), the overlap is clinically recognized. Breath testing is the most common method used in clinical settings to assess for SIBO, although its accuracy and interpretation remain subjects of ongoing discussion in the scientific literature.

How Dietary Diversity Affects the Microbiome

Diet is one of the most powerful modulators of gut microbial composition. A diverse diet rich in varied plant fibers generally supports a more diverse microbiome, while a diet dominated by ultra-processed foods tends to reduce microbial diversity over time. Interestingly, the low-FODMAP diet — while often effective at reducing IBS symptoms in the short term — may also reduce the abundance of certain beneficial bacterial groups if followed for an extended period without careful reintroduction.

Specific types of dietary fiber (prebiotics) feed particular bacterial groups. For example, fermentable fibers found in foods such as onions, garlic, and legumes are metabolized by certain bacteria to produce short-chain fatty acids, which have been associated with beneficial effects on gut barrier function and immune regulation. However, these same fibers can trigger symptoms in individuals whose gut microbial profile leads to excessive gas production. This creates a genuine dilemma: the same food that nourishes beneficial bacteria in one person may cause significant discomfort in another — depending on which microbes are actually present.

This is precisely where the question of individual microbial composition becomes relevant. Knowing which bacteria are present in your gut may help inform more targeted dietary decisions rather than relying on generic recommendations or trial-and-error elimination.

How Can I Test My Gut Health? The Role of Microbiome Testing in IBS

Gut microbiome testing has emerged as a tool that may provide additional insight into the composition and functional potential of an individual's gut microbial community. It is important to state clearly from the outset: microbiome testing does not diagnose IBS, and it does not replace a clinical evaluation by a qualified healthcare professional. Rather, it offers a snapshot of the microbial ecosystem that may help contextualize symptoms and inform more personalized approaches to gut health management.

Commercial microbiome tests, such as the gut microbiome test offered by InnerBuddies, typically involve submitting a small stool sample for laboratory analysis.

What a Microbiome Test Measures and What It Reveals

Most commercial microbiome tests use either 16S rRNA gene sequencing or shotgun metagenomic sequencing to identify and quantify the microorganisms present in a stool sample. The resulting report typically includes information such as:

• Microbial diversity indices: a measure of how many different species are present and in what relative proportions. Generally, greater diversity is associated with gut health, although this relationship is not absolute.
• Relative abundance of specific bacterial groups: including genera and species that have been associated with beneficial functions (such as short-chain fatty acid producers) and those that have been linked with inflammatory or symptom-generating potential.
• Functional potential: an inference of what metabolic capabilities the microbial community possesses, such as the capacity to produce certain gases, metabolize bile acids, or synthesize vitamins.
• Presence of gas-producing microbes: identification of organisms known to produce hydrogen, methane, or hydrogen sulfide, which may be relevant to understanding bloating and distension.

This information provides a baseline map of the gut ecosystem. Rather than guessing which dietary or lifestyle changes might help, individuals have access to objective data about their own microbial composition. Over time, repeat testing — for example, through a subscription such as the gut health membership — can track how the microbiome changes in response to dietary interventions, stress management, or other lifestyle modifications.

What are the Limitations of Microbiome Testing?

While microbiome testing can generate valuable descriptive information, it is essential to understand its limitations:

• Association, not causation: identifying that certain bacteria are present at higher or lower levels than a reference range does not prove that those bacteria are causing your symptoms. The relationship between microbial composition and IBS symptoms is complex and not fully understood.
• No diagnostic capability: a microbiome test cannot tell you whether you have IBS, SIBO, IBD, or any other medical condition. It is not a diagnostic tool.
• Symptoms cannot be explained by composition alone: knowing which bacteria are present does not reveal why you are experiencing specific symptoms, because symptoms arise from interactions between the microbiome, the immune system, the nervous system, diet, and psychological state.
• No guaranteed intervention: a test result cannot tell you which specific dietary change, probiotic, or treatment will resolve your symptoms. It provides information, not prescriptions.
• Snapshot in time: the microbiome is dynamic and can change with diet, stress, medications, illness, and other factors. A single test provides a momentary view rather than a permanent characterization.
• Reference ranges are evolving: what constitutes a "healthy" microbiome is still being defined by the scientific community, and reference ranges may differ between laboratories.

These limitations do not render microbiome testing useless. They mean that results must be interpreted carefully, with appropriate context, and alongside clinical judgment.

Is Microbiome Testing Right for You? When Testing May Be Useful

Deciding whether to pursue microbiome testing involves considering what kind of information you are seeking. A clinical diagnosis from a healthcare professional is essential and non-negotiable, particularly if you are experiencing gastrointestinal symptoms. Once a diagnosis has been established and serious conditions have been excluded, a microbiome assessment may offer a complementary layer of insight.

Individuals who may find microbiome testing particularly useful include:

• Those with persistent bloating or digestive discomfort who want to understand their microbial composition beyond symptom labels.
• Individuals who have not responded well to standard dietary or pharmacological interventions and want additional data to guide more targeted changes.
• People interested in understanding how their gut microbiome changes over time in response to lifestyle modifications.
• Those who value data-driven approaches to health and want to move beyond generic recommendations.

Conversely, microbiome testing is not appropriate as a substitute for urgent medical evaluation. If you are experiencing severe GI bleeding, unexplained rapid weight loss, persistent fever, or other red flag symptoms, seeking immediate medical care is the priority. Similarly, if you have not yet been evaluated by a healthcare professional, that should be your first step before pursuing any additional testing.

How to Use the Results with Your Healthcare Provider

The most effective approach to microbiome testing is one that supplements — rather than replaces — professional medical care. A treating physician, gastroenterologist, or registered dietitian may find microbiome results useful when developing a personalized management plan. For example, if a test reveals that short-chain fatty acid–producing bacteria are present at lower levels, a dietitian may consider whether gradual reintroduction of specific prebiotic foods could support those bacterial populations. Alternatively, if gas-producing organisms are abundant, a dietitian might adjust the approach to fermentable carbohydrates accordingly.

Additionally, microbiome testing can be used as a monitoring tool rather than a one-time diagnostic snapshot. By repeating the test after a defined period of intervention — such as a dietary change, probiotic trial, or stress reduction program — individuals and their healthcare providers can observe whether the intervention is shifting the microbial composition in the desired direction. This longitudinal perspective transforms microbiome testing from a static "crystal ball" into a dynamic feedback mechanism for personalized gut health optimization.

When discussing results with a healthcare provider, it is helpful to bring the full report, ask questions about how specific findings relate to your symptom pattern, and remain open to the possibility that the relationship between your microbiome and your symptoms may not have a simple, one-directional explanation.

Key Takeaways

• IBS is a functional gastrointestinal disorder diagnosed using clinical criteria (Rome IV) and the exclusion of other conditions through targeted testing.
• The core symptoms include abdominal pain, bloating, and changes in bowel habits, but these symptoms vary enormously between individuals.
• Red flag symptoms such as weight loss, rectal bleeding, or anemia require further investigation to rule out conditions such as IBD, celiac disease, or colorectal cancer.
• IBS is understood as a disorder of gut-brain interaction involving altered motility, visceral hypersensitivity, and potentially gut microbiome dysbiosis.
• Research suggests that many individuals with IBS have a gut microbial composition that differs from those without the condition, although causation has not been definitively established.
• Small intestinal bacterial overgrowth (SIBO) can produce symptoms that overlap with IBS, particularly bloating and distension.
• Symptoms alone do not reveal the underlying mechanism, and one-size-fits-all treatments may be ineffective due to individual variability in gut microbial composition, genetics, and physiology.
• Gut microbiome testing provides a snapshot of microbial composition and functional potential but cannot diagnose any medical condition or identify the cause of symptoms on its own.
• Microbiome results are most useful when interpreted alongside a healthcare provider as part of a broader, personalized approach to gut health.
• The gut microbiome is dynamic and can change over time in response to diet, stress, medications, and other factors, making longitudinal tracking potentially informative.

Frequently Asked Questions

Can a microbiome test diagnose IBS?

No. IBS is diagnosed clinically using symptom criteria and the exclusion of other conditions. A microbiome test provides information about gut microbial composition but cannot diagnose IBS or any other medical condition. It should be viewed as a complementary informational tool rather than a diagnostic instrument.

How is IBS different from inflammatory bowel disease (IBD)?

IBS is a functional disorder in which the gut appears structurally normal but does not function properly, whereas IBD involves visible inflammation and tissue damage in the digestive tract. IBD is diagnosed using endoscopy, imaging, and inflammatory markers, while IBS is diagnosed based on symptom criteria and the absence of red flags. Both can cause abdominal pain and altered bowel habits, which is why proper evaluation is important.

What are the Rome IV criteria for IBS?

The Rome IV criteria define IBS as recurrent abdominal pain occurring at least one day per week on average over the previous three months, associated with two or more of the following: a relationship between pain and defecation, a change in stool frequency, or a change in stool form. These criteria help healthcare professionals make a consistent, evidence-based diagnosis.

What is gut microbiome dysbiosis?

Dysbiosis refers to a state in which the composition or function of the gut microbial community differs from what is typically observed in healthy individuals. In the context of IBS, dysbiosis may involve reduced microbial diversity, shifts in the relative abundance of certain bacterial groups, or altered metabolic activity. Research suggests dysbiosis is commonly observed in IBS populations, though its role in causing symptoms remains under investigation.

Can stress really cause IBS symptoms?

Stress is a well-documented biological trigger for IBS symptoms. The gut-brain axis connects the central nervous system with the digestive tract, and stress hormones can directly influence gut motility, sensitivity, and immune function. This does not mean IBS is purely psychological; it means that the brain and gut are physiologically interconnected in ways that produce real symptoms.

Is SIBO the same thing as IBS?

No, SIBO and IBS are distinct conditions, although they share overlapping symptoms and can coexist. SIBO involves the presence of excessive bacteria in the small intestine, while IBS is a broader functional disorder. Some individuals diagnosed with IBS may have underlying SIBO contributing to their symptoms, which is why some healthcare providers consider testing for SIBO when bloating is a prominent feature.

How long does it take to diagnose IBS?

The time frame varies depending on the individual's symptom pattern, the presence or absence of red flags, and the healthcare system. In many cases, a diagnosis can be made within one or two consultations if the presentation is typical and no red flags are present. If additional testing is needed, the process may take several weeks or months.

Can the low-FODMAP diet harm my gut microbiome?

Research indicates that prolonged adherence to a strict low-FODMAP diet may reduce the abundance of certain beneficial bacterial groups, particularly those that ferment prebiotic fibers. This is why the diet is designed in phases, with a gradual reintroduction process intended to identify specific triggers while maintaining a diverse and nourishing dietary pattern overall.

What is the difference between 16S rRNA sequencing and metagenomic sequencing?

16S rRNA sequencing targets a specific gene present in bacteria, allowing identification of which bacterial groups are present and in what relative proportions. Shotgun metagenomic sequencing reads all genetic material in the sample, providing broader information including potential functional capabilities of the microbial community. Both approaches generate useful compositional data, though they differ in depth and resolution.

Should I stop seeing my doctor if I get a microbiome test?

No. Microbiome testing is intended to complement, not replace, professional medical care. Ongoing evaluation by a healthcare provider remains essential, particularly if symptoms change, worsen, or new features emerge. Microbiome data can be most valuable when discussed with a doctor or dietitian who can integrate it into a broader clinical picture.

How often should I repeat a microbiome test?

The optimal frequency depends on your goals and any interventions you are undertaking. If you have made significant dietary or lifestyle changes and want to observe their effect on your gut ecosystem, repeat testing after several months may provide meaningful comparison data. Some individuals choose ongoing testing through subscription services to track longer-term trends.

Can children have microbiome testing for IBS symptoms?

While children can experience IBS-like symptoms, any gastrointestinal symptoms in a child should be evaluated by a pediatric healthcare professional before pursuing additional testing. The diagnostic approach and management considerations for children differ from those for adults, and professional guidance should always come first.

Conclusion: Moving from a Generic Diagnosis to a Personalized Picture

Diagnosing irritable bowel syndrome is a structured clinical process based on symptom criteria and the exclusion of other conditions — and this process remains essential and non-negotiable. However, a diagnosis of IBS, while valuable, describes a pattern rather than a mechanism. It tells you that your symptoms are real and consistent with a recognized condition, but it does not reveal the specific biological processes or microbial composition underlying your individual experience.

Because two people with the same diagnosis can have entirely different triggers, microbial profiles, and treatment responses, personalized gut health requires looking beyond symptom labels. Understanding which bacteria are present in your gut, what they are capable of producing, and how your microbial community changes over time may provide the additional context needed to make more informed decisions about diet, lifestyle, and treatment — always in partnership with qualified healthcare professionals.

Tools such as a personalized microbiome analysis offer one avenue for gaining this deeper understanding. While they cannot diagnose, cure, or replace medical judgment, they can serve as a valuable informational resource for individuals seeking to move beyond guesswork toward a more data-informed, personalized picture of their gut health. Combined with professional care, thoughtful interpretation, and a recognition of scientific uncertainty, microbiome insight may help transform the management of IBS from a generic protocol into a genuinely individualized strategy.

Keywords

diagnosing irritable bowel syndrome, IBS diagnosis, Rome IV criteria, functional gastrointestinal disorder, gut-brain axis, visceral hypersensitivity, gut microbiome, dysbiosis, microbial diversity, small intestinal bacterial overgrowth, SIBO, IBS symptoms, IBS-D, IBS-C, IBS-M, low-FODMAP diet, microbiome testing, personalized gut health, gut microbiome test, microbiome composition, intestinal permeability, individual variability, gut health, red flag symptoms, fecal calprotectin, clinical diagnosis, microbiome imbalance, prebiotics, short-chain fatty acids, personalized microbiome analysis